Cargando…

Time to diagnosis of symptomatic gastric and oesophageal cancer in the Netherlands: Where is the room for improvement?

BACKGROUND: An efficient diagnostic pathway and early stage diagnosis for cancer patients is widely pursued. This study aims to chart the duration of the diagnostic pathway for patients with symptomatic oesophageal and gastric cancer, to identify factors associated with long duration and to assess t...

Descripción completa

Detalles Bibliográficos
Autores principales: van Erp, NF, Helsper, CW, Slottje, P, Brandenbarg, D, Büchner, FL, van Asselt, KM, Muris, JWM, Kortekaas, MF, Peeters, PHM, de Wit, NJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268938/
https://www.ncbi.nlm.nih.gov/pubmed/32250202
http://dx.doi.org/10.1177/2050640620917804
_version_ 1783541697478656000
author van Erp, NF
Helsper, CW
Slottje, P
Brandenbarg, D
Büchner, FL
van Asselt, KM
Muris, JWM
Kortekaas, MF
Peeters, PHM
de Wit, NJ
author_facet van Erp, NF
Helsper, CW
Slottje, P
Brandenbarg, D
Büchner, FL
van Asselt, KM
Muris, JWM
Kortekaas, MF
Peeters, PHM
de Wit, NJ
author_sort van Erp, NF
collection PubMed
description BACKGROUND: An efficient diagnostic pathway and early stage diagnosis for cancer patients is widely pursued. This study aims to chart the duration of the diagnostic pathway for patients with symptomatic oesophageal and gastric cancer, to identify factors associated with long duration and to assess the association of duration with tumour stage at diagnosis. METHODS: This was a retrospective cohort study, using electronic health records of six routine primary care databases covering about 640,000 patients, partly linked to the Netherlands Cancer Registry. Symptomatic patients with oesophageal and gastric cancer (2010–2015) that presented in primary care were included. Duration of four diagnostic intervals was determined: patient interval; first symptoms to primary care consultation, primary care interval; consultation to referral, secondary care interval; referral to diagnosis, and the diagnostic interval; consultation to diagnosis. Characteristics associated with ‘long duration’ (≥P75 duration) were assessed using log-binomial regression. Median durations were stratified for tumour stages. RESULTS: Among 312 symptomatic patients with upper gastrointestinal cancer, median durations were: patient interval: 29 days (interquartile interval 15–73), primary care interval: 12 days (interquartile interval 1–43), secondary care interval: 13 days (interquartile interval 6–29) and diagnostic interval: 31 days (11–74). Patient interval duration was comparable for patients with and without alarm symptoms. Absence of cancer-specific alarm symptoms was associated with ‘long duration’ of primary care interval and secondary care interval: relative risk 5.0 (95% confidence interval 2.7–9.1) and 2.1 (95% confidence interval 1.3–3.7), respectively. Median diagnostic interval duration for local stage disease was 51 days (interquartile interval 13–135) versus 27 days (interquartile interval 11–71) for advanced stage (p = 0.07). CONCLUSION: In the diagnostic pathway of upper gastrointestinal cancers, the longest interval is the patient interval. Reducing time to diagnosis may be achieved by improving patients’ awareness of alarm symptoms and by diagnostic strategies which better identify cancer patients despite low suspicion.
format Online
Article
Text
id pubmed-7268938
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-72689382020-06-11 Time to diagnosis of symptomatic gastric and oesophageal cancer in the Netherlands: Where is the room for improvement? van Erp, NF Helsper, CW Slottje, P Brandenbarg, D Büchner, FL van Asselt, KM Muris, JWM Kortekaas, MF Peeters, PHM de Wit, NJ United European Gastroenterol J Original Articles BACKGROUND: An efficient diagnostic pathway and early stage diagnosis for cancer patients is widely pursued. This study aims to chart the duration of the diagnostic pathway for patients with symptomatic oesophageal and gastric cancer, to identify factors associated with long duration and to assess the association of duration with tumour stage at diagnosis. METHODS: This was a retrospective cohort study, using electronic health records of six routine primary care databases covering about 640,000 patients, partly linked to the Netherlands Cancer Registry. Symptomatic patients with oesophageal and gastric cancer (2010–2015) that presented in primary care were included. Duration of four diagnostic intervals was determined: patient interval; first symptoms to primary care consultation, primary care interval; consultation to referral, secondary care interval; referral to diagnosis, and the diagnostic interval; consultation to diagnosis. Characteristics associated with ‘long duration’ (≥P75 duration) were assessed using log-binomial regression. Median durations were stratified for tumour stages. RESULTS: Among 312 symptomatic patients with upper gastrointestinal cancer, median durations were: patient interval: 29 days (interquartile interval 15–73), primary care interval: 12 days (interquartile interval 1–43), secondary care interval: 13 days (interquartile interval 6–29) and diagnostic interval: 31 days (11–74). Patient interval duration was comparable for patients with and without alarm symptoms. Absence of cancer-specific alarm symptoms was associated with ‘long duration’ of primary care interval and secondary care interval: relative risk 5.0 (95% confidence interval 2.7–9.1) and 2.1 (95% confidence interval 1.3–3.7), respectively. Median diagnostic interval duration for local stage disease was 51 days (interquartile interval 13–135) versus 27 days (interquartile interval 11–71) for advanced stage (p = 0.07). CONCLUSION: In the diagnostic pathway of upper gastrointestinal cancers, the longest interval is the patient interval. Reducing time to diagnosis may be achieved by improving patients’ awareness of alarm symptoms and by diagnostic strategies which better identify cancer patients despite low suspicion. SAGE Publications 2020-04-06 2020-06 /pmc/articles/PMC7268938/ /pubmed/32250202 http://dx.doi.org/10.1177/2050640620917804 Text en © Author(s) 2020 https://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Articles
van Erp, NF
Helsper, CW
Slottje, P
Brandenbarg, D
Büchner, FL
van Asselt, KM
Muris, JWM
Kortekaas, MF
Peeters, PHM
de Wit, NJ
Time to diagnosis of symptomatic gastric and oesophageal cancer in the Netherlands: Where is the room for improvement?
title Time to diagnosis of symptomatic gastric and oesophageal cancer in the Netherlands: Where is the room for improvement?
title_full Time to diagnosis of symptomatic gastric and oesophageal cancer in the Netherlands: Where is the room for improvement?
title_fullStr Time to diagnosis of symptomatic gastric and oesophageal cancer in the Netherlands: Where is the room for improvement?
title_full_unstemmed Time to diagnosis of symptomatic gastric and oesophageal cancer in the Netherlands: Where is the room for improvement?
title_short Time to diagnosis of symptomatic gastric and oesophageal cancer in the Netherlands: Where is the room for improvement?
title_sort time to diagnosis of symptomatic gastric and oesophageal cancer in the netherlands: where is the room for improvement?
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268938/
https://www.ncbi.nlm.nih.gov/pubmed/32250202
http://dx.doi.org/10.1177/2050640620917804
work_keys_str_mv AT vanerpnf timetodiagnosisofsymptomaticgastricandoesophagealcancerinthenetherlandswhereistheroomforimprovement
AT helspercw timetodiagnosisofsymptomaticgastricandoesophagealcancerinthenetherlandswhereistheroomforimprovement
AT slottjep timetodiagnosisofsymptomaticgastricandoesophagealcancerinthenetherlandswhereistheroomforimprovement
AT brandenbargd timetodiagnosisofsymptomaticgastricandoesophagealcancerinthenetherlandswhereistheroomforimprovement
AT buchnerfl timetodiagnosisofsymptomaticgastricandoesophagealcancerinthenetherlandswhereistheroomforimprovement
AT vanasseltkm timetodiagnosisofsymptomaticgastricandoesophagealcancerinthenetherlandswhereistheroomforimprovement
AT murisjwm timetodiagnosisofsymptomaticgastricandoesophagealcancerinthenetherlandswhereistheroomforimprovement
AT kortekaasmf timetodiagnosisofsymptomaticgastricandoesophagealcancerinthenetherlandswhereistheroomforimprovement
AT peetersphm timetodiagnosisofsymptomaticgastricandoesophagealcancerinthenetherlandswhereistheroomforimprovement
AT dewitnj timetodiagnosisofsymptomaticgastricandoesophagealcancerinthenetherlandswhereistheroomforimprovement